购物车
全部删除
您的购物车当前为空
别名 Ocrevus
Anti-Ocrelizumab Antibody (2D729) 是一种 Rabbit 抗体,靶向 Ocrelizumab。Anti-Ocrelizumab Antibody (2D729) 可用于 ELISA, Sandwich ELISA, Competitive ELISA。
Anti-Ocrelizumab Antibody (2D729) 是一种 Rabbit 抗体,靶向 Ocrelizumab。Anti-Ocrelizumab Antibody (2D729) 可用于 ELISA, Sandwich ELISA, Competitive ELISA。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 40 μg | ¥ 1,609 | 5日内发货 |
| 产品描述 | Anti-Ocrelizumab Antibody (2D729) is a Rabbit antibody targeting Ocrelizumab. Anti-Ocrelizumab Antibody (2D729) can be used in ELISA, Sandwich ELISA, Competitive ELISA. |
| 别名 | Ocrevus |
| Ig Type | IgG, κ |
| 克隆号 | 2D729 |
| 特异性 | Ocrelizumab |
| 应用 | ELISASandwich ELISACompetitive ELISA |
| 推荐剂量 | ELISA: 0.01-1 µg/ml; Sandwich ELISA: 0.5-2 μg/ml; Competitive ELISA: 1-10 μg/ml |
| 抗体种类 | Monoclonal |
| 宿主来源 | Rabbit |
| 纯化方式 | Protein A affinity column |
| 性状 | Lyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL. |
| 缓冲液 | Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide. |
| 研究背景 | Ocrelizumab is a recombinant humanized monoclonal IgG1 antibody that selectively targets B-cells expressing the CD20 antigen. It is indicated for the treatment of primary progressive or relapsing forms of multiple sclerosis (MS). Compared to non-humanized CD20 antibodies like rituximab, ocrelizumab is anticipated to have a lower potential for immunogenicity with repeated infusions. This improved benefit-to-risk profile is beneficial for patients with MS. |
| 偶联 | Unconjugated |
| 免疫原 | Ocrelizumab |
| 储存方式 | The lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |
| 存储 | -20°C for 1 year |